Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Increasing pazopanib exposure by splitting intake moments

Trial Profile

Increasing pazopanib exposure by splitting intake moments

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Feb 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pazopanib (Primary)
  • Indications Renal cell carcinoma; Soft tissue sarcoma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 04 Feb 2020 Primary endpoint, increase in pharmacokinetic exposure, measured as Cmin and AUC0-24h, when switching patients from a once daily (QD) dosing scheme to a twice daily (BID) dosing scheme, has been met as per results published in the Clinical Pharmacokinetics
    • 04 Feb 2020 Results published in the Clinical Pharmacokinetics
    • 04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top